Shared genetic susceptibility between trigger finger and carpal tunnel syndrome: a genome-wide association study [0.03%]
弹响指与腕管综合征的共有遗传易感性：一项全基因组关联研究
Benjamin Patel,Sam O Kleeman,Drew Neavin et al.
Benjamin Patel et al.
Background: Trigger finger and carpal tunnel syndrome are the two most common non-traumatic connective tissue disorders of the hand. Both of these conditions frequently co-occur, often in patients with rheumatoid arthriti...
Potential for false decline of anti-SARS-CoV-2 spike antibody titers after COVID-19 vaccination [0.03%]
新冠疫苗接种后抗SARS-CoV-2刺突蛋白抗体滴度假阴性的可能性
Meryl Waldman,David B Sacks,Lilian Howard et al.
Meryl Waldman et al.
Omicron breakthrough infections in patients with immune-mediated inflammatory diseases [0.03%]
免疫介导性炎症性疾病患者感染奥密克戎病毒的突破病例
Jean W Liew,Sebastian E Sattui
Jean W Liew
SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period [0.03%]
免疫介导性炎症性疾病患者 Omicron 流行期间的新冠病毒感染症状突破事件
Laura Boekel,Yaëlle R Besten,Femke Hooijberg et al.
Laura Boekel et al.
Preventive medicine in rheumatology: COVID-19 and its lessons for better health outcomes [0.03%]
风湿病学的预防医学：从COVID-19中学到的改善健康结局的教训
David F L Liew,Philip C Robinson
David F L Liew
COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study [0.03%]
针对接受免疫抑制治疗的患者接种新冠疫苗预防奥密克戎感染和住院的有效性：回顾性队列研究
Malcolm Risk,Salim S Hayek,Elena Schiopu et al.
Malcolm Risk et al.
Background: There is a scarcity of research regarding the effectiveness of the mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in patients taking immunosuppressant medications, and no data are publish...
Ria Lassaunière,Caroline T Tiemessen
Ria Lassaunière
Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study [0.03%]
自身免疫性炎症性疾病患者的SARS-CoV-2疫苗接种反应的强度和持久性：前瞻性队列研究
David Simon,Koray Tascilar,Filippo Fagni et al.
David Simon et al.
Background: Concerns have been raised about the reduced immunogenicity of vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory diseases and the higher risk of breakthrough infections. The objective of...
Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial [0.03%]
早期迪普叶特伦病的抗肿瘤坏死因子治疗效果（RIDD研究）：一项随机、双盲、安慰剂对照的二期临床试验
Jagdeep Nanchahal,Catherine Ball,Ines Rombach et al.
Jagdeep Nanchahal et al.
Background: Dupuytren's disease is a common fibrotic condition that causes the fingers to flex irreversibly into the palm. Treatments for late-stage disease all have limitations, and there is no approved treatment for ear...
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study [0.03%]
与风湿病患者有关的新冠肺炎相关死亡的环境和社会因素：一项观察性研究
Zara Izadi,Milena A Gianfrancesco,Gabriela Schmajuk et al.
Zara Izadi et al.
Background: Differences in the distribution of individual-level clinical risk factors across regions do not fully explain the observed global disparities in COVID-19 outcomes. We aimed to investigate the associations betw...